Guidelines

Tyrosine kinase inhibitor discontinuation in patients with chronic myelogenous leukaemia: A retrospective study and review of the literature

March 2021
Highlights in CML and MPN

February 2021
Highlights in frontline therapy of multiple myeloma

February 2021
Highlights in relapsed/refractory multiple myeloma

February 2021
Highlights in aggressive lymphoma

February 2021
Highlights in acute myeloid leukaemia

February 2021
Highlights in chronic lymphocytic leukaemia

February 2021
Highlights in red blood cell disorders

February 2021
Highlights in haematopoietic stem cell transplantation

February 2021
Highlights in myelodysplastic syndrome

February 2021

Top